US 10537611
Methods of treating lung cancer
granted A61KA61K38/179A61K39/395
Quick answer
US patent 10537611 (Methods of treating lung cancer) held by Five Prime Therapeutics, Inc. expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/179, A61K39/395, A61K45/00, A61K45/06